Trial intelligence / Profile preview

HARMONY II: BF2.649 with or without modafinil for cataplexy in narcolepsy

2008-007845-29Phase 3Completed

Sponsor
Bioprojet
Start
Feb 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of pitolisant in narcolepsy and cataplexy (2 arms), sponsored by Bioprojet. Primary endpoint: Change from baseline in weekly cataplexy attacks. Started Feb 2009; status: completed.

02

Drugs

pitolisant
03

Conditions

narcolepsycataplexy

Beyond the preview

Go deeper on 2008-007845-29.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-007845-29.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call